3D Printing Market to Witness a Pronounce Growth During 2021 – 2028: Grand View Research Inc.

 3D Printing Market Growth & Trends

The global 3D printing market size is estimated to reach USD 62.79 billion by 2028, according to the new report by Grand View Research, Inc. The market is expected to witness a CAGR of 21.0% from 2021 to 2028. 3D Printing (3DP) is also referred to as Additive Manufacturing (AM), as it involves successive addition of layers of materials in various 2D shapes using an additive process. These layered 2D shapes build upon one another to form a three-dimensional object. The process is different from the subtractive method of production, which begins with a block of material and the unnecessary material is ground out to obtain the desired object.

3D printing is widely adopted in the industrial sector owing to the growing need for enhanced product manufacturing and a shorter time to market. The industrial vertical happens to be the most significant adopter of the 3D printing technology and eventually leading to the highest market share of 3D printers for industrial applications over the forecast period. Additive manufacturing is anticipated to evolve over the forecast period.

3D printing continues to gain popularity among hobbyists and innovators. While individuals are using 3D printing for domestic and personal purposes, universities and educational institutes are using 3D printing for conducting technical training. The market is subject to witness a considerable economical appearance rather than being just a labor-intensive industrial manufacturing technique. Particularly in developing economies, such as Brazil, South Africa, and India, machining shops have managed to adopt alternative business models by installing 3D printers and offer related services, such as 3D printing materials, filaments, 3D modeling, and 3D printer software.

Based on application, the market has been segmented further into prototyping, tooling, and functional parts. Apart from the industrial vertical, the automotive, healthcare, and aerospace and defense verticals are among the leading adopters of 3D printing technology. Incumbents of these verticals have an emphasis on accuracy, enhanced product designing, reliability, shorter time to market, and economical production processes. Given that additive manufacturing possess can offer all these benefits, the adoption of three-dimensional printers by the automotive, healthcare, and aerospace and defense verticals is expected to gain traction over the forecast period.

The 3D printing and related technologies are evolving continuously in line with the intensive R&D activities being undertaken and the aggressive investments being made by the private sector as well as the public sector. Government funding and encouraging initiatives being undertaken in developed economies are prompting manufacturers to pursue improvements in technology and the adoption of new technologies.

North America accounted for the largest market share of more than 35% in 2020 as a result of the extensive adoption of 3D printers for 3D designing, 3D modeling, and 3D manufacturing in several industries. On the other hand, the Asia Pacific region has emerged as a manufacturing hub owing to an expanding consumer base as well as the continued foreign investments happening in the region. Hence, the Asia Pacific regional market is expected to witness remarkable growth over the forecast period.

3D printing technology happens to be a capital-intensive technology. At the same time, manufacturers are holding to their misconception about prototyping rather than realizing the advantages associated with 3D printing. Moreover, the market lacks the standard process controls and a skilled workforce required for 3D printing. These are some of the factors that are expected to restrain the market growth. However, government initiatives aimed at increasing awareness and promoting the benefits of adopting 3D printers are expected to help in countering the market restraints.

Request a free sample copy or view report summary: 3D Printing Market Report

3D Printing Market Report Highlights

• 3D printing technology is gaining traction owing to the ability of the technology to offer accurate and rapid prototyping and optimize the time to market
• Increasing adoption of 3D printers in the healthcare, automotive, and consumer electronics verticals is likely to drive the market growth significantly
• Demand for desktop 3D printers is expected to increase over the forecast period, as 3D printing is gaining popularity among hobbyists for domestic, household, and personal usage as well as in the education sector for training purposes
• The prototyping segment dominated the market in 2020 and is expected to expand its market share to more than 55% by 2028
• The polymer segment contributed to almost half of the entire industry share. However, the metal segment is expected to dominate the market in the next seven years. This is attributed to the increasing demand for metal 3D printing from industrial verticals such as automotive and aerospace and defense
• The desktop 3D printing segment, which has been segmented further into educational purpose, fashion and jewelry, objects, dental, food, and others, is expected to adopt the 3D printing technique aggressively over the forecast period
• The Asia Pacific regional market, which is emerging as a manufacturing hub for several industry verticals, is anticipated to grow significantly as the continued urbanization triggers the need for infrastructure and prompts the automotive, consumer electronics, aerospace and defense, and healthcare verticals to adopt 3D printing, particularly in countries, including China, Japan, and South Korea

Access Press Release@ https://www.grandviewresearch.com/press-release/global-3d-printing-market

3D Printing Market Segmentation

Grand View Research has segmented the global 3D printing market based on component, printer type, technology, software, application, vertical, material, and region:

3D Printing Component Outlook (Revenue, USD Million, 2017 - 2028)

• Hardware
• Software
• Services

3D Printing Printer Type Outlook (Revenue, USD Million, 2017 - 2028)

• Desktop 3D Printer
• Industrial 3D Printer

3D Printing Technology Outlook (Revenue, USD Million, 2017 - 2028)

• Stereolithography
• Fused Deposition Modelling
• Selective Laser Sintering
• Direct Metal Laser Sintering
• Polyjet Printing
• Inkjet printing
• Electron Beam Melting
• Laser Metal Deposition
• Digital Light Processing
• Laminated Object Manufacturing
• Others

3D Printing Software Outlook (Revenue, USD Million, 2017 - 2028)

• Design Software
• Inspection Software
• Printer Software
• Scanning Software

3D Printing Application Outlook (Revenue, USD Million, 2017 - 2028)

• Prototyping
• Tooling
• Functional Parts

3D Printing Vertical Outlook (Revenue, USD Million, 2017 - 2028)

• Industrial 3D Printing
  • Automotive
  • Aerospace & Defense
  • Healthcare
  • Consumer Electronics
  • Industrial
  • Power & Energy
  • Others
• Desktop 3D Printing
  • Educational Purpose
  • Fashion & Jewelry
  • Objects
  • Dental
  • Food
  • Others

3D Printing Material Outlook (Revenue, USD Million, 2017 - 2028)

• Polymer
• Metal
• Ceramic

3D Printing Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
• South America
  • Brazil
• Middle East & Africa

List of Key Players in the 3D Printing Market

• Stratasys Ltd.
• 3D Systems, Inc.
• 3D Ceram
• GE Additive
• HP Inc.
• Tiertime
• EnvisionTec, Inc.
• Dassault Systemes

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

COVID-19 Clinical Trials Market Pegged For Strong Growth During 2020-2027: Grand View Research Inc.

 COVID-19 Clinical Trials Market Growth & Trends

The global COVID-19 clinical trials market size is expected to reach USD 9.9 billion by 2027, registering a CAGR of 9.5% during the forecast period, according to a new report by Grand View Research, Inc. An increasing number of deaths due to coronavirus is creating a need to develop effective treatments, thereby boosting the market growth. Also, the underlying economic profits for first movers are encouraging pharmaceutical players to invest in clinical trial studies for COVID-19.

The current pandemic poses an acute health risk to the entire population. A key to successfully fighting COVID-19 lies in clinical research. At present, almost all the major research-based pharmaceutical companies, many other biotechnology and pharmaceutical companies, as well as research institutes are engaged in a race to develop an effective treatment against coronavirus. There are currently 661 unique compounds in development against COVID-19, of which 292 are drugs, 173 are vaccines and 196 are antivirals.

The regulators in the U.S. and Europe also offer various options for action and procedural facilitation to enable faster access to effective vaccines and drugs to combat the pandemic. In March 2020, the Solidarity Trial-an international clinical trial by the World Health Organization (WHO)-was launched to find effective treatment against COVID-19. In May 2020, WHO also announced an international alliance for developing various candidate vaccines to stop the spread of coronavirus disease, calling this effort the Solidarity trial for vaccines.

The current scenario across the globe and the need to come up with treatment options has also led to the fast-track of clinical trials. Hence, in March 2020, the Food and Drug Administration (FDA) launched a Coronavirus Treatment Acceleration Program (CTAP) for the likely therapies to accelerate the development of the treatment for the pandemic caused by a coronavirus. Recently in May 2020, the U.S. FDA granted fast track title to Moderna’s mRNA vaccine candidate, mRNA-1273, to protect against COVID-19.

Request a free sample copy or view report summary: COVID-19 Clinical Trials Market Report

COVID-19 Clinical Trials Market Report Highlights

• Phase II COVID-19 clinical trials dominated the market with a share of 35.0% in 2020. This is attributed to the maximum number of products currently in development.
• The vaccines segment accounted for the largest share of 77.1% in 2020 owing to the increasing investments towards it.
• Europe held 46.8% of the market share in 2020. Favorable government initiatives such as the UK’s “ACCORD” clinical trial program are contributing to market growth.
• The Asia Pacific region is projected to witness the fastest CAGR of 11.8% during the forecast period as the increasing number of biotechnology firms are looking at the region for their COVID-19 trials to take advantage of the large patient pool and fast-track procedures.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-covid-19-clinical-trials-market

COVID-19 Clinical Trials Market Segmentation

Grand View Research has segmented the global COVID-19 clinical trials market based on phase, product, and region:

COVID-19 Clinical Trials Market Phase Outlook (Revenue, USD Million, 2016 - 2027)

• Phase I
• Phase II
• Phase III
• Phase IV
• Others

COVID-19 Clinical Trials Market Product Outlook (Revenue, USD Million, 2016 - 2027)

• Therapeutics
• Vaccines

COVID-19 Clinical Trials Market Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • The U.S.
  • Canada
• Europe
  • The U.K.
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• The Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of COVID-19 Clinical Trials Market

• Moderna, Inc.
• GlaxoSmithKline plc
• Pfizer Inc.
• Johnson & Johnson
• Gilead Sciences Inc.
• INOVIO Pharmaceuticals
• AbbVie Inc.
• BioNTech SE
• Novavax
• Takeda

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Augmented Reality & Virtual Reality In Healthcare Market Set to Witness an Uptick during 2021 to 2028: Grand View Research Inc.

 Augmented Reality & Virtual Reality In Healthcare Market Growth & Trends

The global augmented reality & virtual reality in healthcare market size is expected to reach USD 9.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 27.2% from 2021 to 2028. Increasing advancements and digital disruptions in the healthcare system, rising healthcare expenditure, and the rising need for efficient and innovative solutions to enhance clinical and operational outcomes are contributing to the growth of the market. Augmented reality (AR) and virtual reality (VR)technologies are witnessing widespread adoption in surgical departments, simulation labs, education and training, and chronic pain management.

The rising number of complex surgeries is driving the demand for VR-based models to assist the surgeon. AR-based apps are used in multiple spaces such as training and education modules and patient care management tools. Innovators are receiving recognition in the form of increased investments by venture capitalists and collaboration opportunities by established players. For instance, in September 2020 OssoVR rose funding of USD 14.0 million and planned to utilize the funding towards developing virtual reality-based surgical and medical device training modules.

The hardware component segment witnessed the highest adoption owing to the rising adoption of AR and VR into different fields of healthcare. These devices range from desktops to wearable devices to display devices. Due to their audio-visual significance AR and VR is being widely adopted in education, simulation, telemedicine, and data visualization. Increasing product development in this space is contributing to market growth. For instance, in February 2019 Philips Healthcare launched a mixed reality solution by collaborating with Azurion and Microsoft. However, the services segment is expected to witness a significant CAGR during the forecast period owing to the growing need to create an immersive experience for the customer. The rising adoption in clinical trials, psychological treatment, advanced diagnostics, surgeries, and body mapping is expected to support market growth.

In addition, AR technological solutions are widely used in surgical procedures, fitness management, education and training, patient care management, medical imaging and is expected to be implemented in many more functionalities. Recent advancements in AR components have reduced the cost of augmented reality solutions and enhanced customer experience. The increasing prevalence of diseases and surgeries along with advancements in healthcare infrastructure and IT are some of the driving forces. Medical education and training using augmented reality technological solutions is also emerging rapidly and is expected to support growth. On the other hand, virtual reality technology is expected to be the fastest-growing region during the forecast period owing to the rapid integration of technology into healthcare services. VR technological solutions are widely used in telemedicine, anatomy visualization, and diagnostics. Additionally, it provides hands-on experience in medical education which is expected to contribute to market growth.

Request a free sample copy or view report summary: Augmented Reality & Virtual Reality In Healthcare Market Report

Augmented Reality & Virtual Reality In Healthcare Market Report Highlights

• The market is anticipated to grow well over the forecast period owing to the rapidly transforming and digitalization of the healthcare space
• Hardware component segment dominated the global augmented reality and virtual reality in healthcare market in 2020, owing to increased use in training, simulation, surgeries, and diagnostics
• The augmented reality technology segment dominated the market in 2020 owing to the growing adoption of inpatient care management, training and education, and medical imaging
• North America dominated the market in 2020 owing to sophisticated healthcare infrastructure and widespread awareness of the benefits of AR and VR in healthcare

Access Press Release@ https://www.grandviewresearch.com/press-release/global-augmented-reality-ar-virtual-reality-vr-in-healthcare-market

Augmented Reality & Virtual Reality In Healthcare Market Segmentation

Grand View Research has segmented the global augmented reality & virtual reality in healthcare market on the basis of component, technology, and region:

AR & VR In Healthcare Component Outlook (Revenue, USD Million, 2016 - 2028)

• Hardware
• Software
• Service

AR & VR In Healthcare Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Augmented Reality
  • Surgical Application
  • Rehabilitation
  • Training and Medical Education
• Virtual Reality
  • Virtual Reality Exposure Therapy (VRET)
  • Simulation
  • Rehabilitation
  • Diagnostics
  • Pain Distraction

AR & VR In Healthcare Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Spain
  • France
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in the Augmented Reality And Virtual Reality In Healthcare Market

• CAE
• GE Healthcare
• Koninklijke Philips N.V.
• Intuitive Surgical
• Siemens Ltd
• Eon Reality, Inc
• Layar
• Bioflight VR
• WorldViz
• TheraSim Inc
• Mindmaze

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Single-cell Analysis Market Set to Record Exponential Growth by 2028: Grand View Research Inc.

 Single-cell Analysis Market Growth & Trends

The global single-cell analysis market size is expected to reach USD 6.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.0% from 2021 to 2028. Expeditious technological advancements over the years have enabled a comprehensive analysis of transcriptome and genome in an individual cell.

Single-cell technology helps in assessing cellular heterogeneity and aids in the analysis of pathways and processes at the molecular level. This technology is evolving at a rapid pace with applications in oncology, immunology, and others. Moreover, the introduction of advanced devices that simplify transcriptomic and proteomics procedures is driving the market. 

Advances in single-cell RNA sequencing (scRNAseq) allow researchers to thoroughly investigate unexplored rare cell types. The development of the microfluidics method has significantly broadened the implementation of single-cell genomic/transcriptomic analysis in the biomedical field. A substantial number of microfluidic devices have been modified for cell dissociation and tissue digestion.

The increasing number of research publications is representative of the increasing investment flow in R&D in this market. As the R&D activities are the base of innovation, these investments signify a healthy growth possibility for this market. Moreover, researchers are engaged in assessing spatial heterogeneity in gene expression profiles at a single cellular level; thus, are anticipated to boost the uptake of consumables and instruments for the analysis.

Request a free sample copy or view report summary: Single-cell Analysis Market Report

Single-cell Analysis Market Report Highlights

• The consumables segment accounted for the largest revenue share due to the high adoption and demand of products offered under this segment
• Given the wide availability of different forms of reagents, this segment is responsible for constant revenue generation
• Owing to the high-end features and the technically advanced analytical options, automated instruments contributed to maximum revenue share
• The oncology segment is majorly benefited by the advancements in single-cell analysis methods
• To avoid risks associated with cancer therapy, single-cell analysis techniques are being heavily adopted for cancer genomics
• There is increasing demand for prenatal diagnosis and non-invasive techniques for the detection of single-gene disorders associated with the fetus
• This has increased the adoption of single-cell analysis for prenatal diagnosis
• Single-cell analysis is being widely employed by various end-users, ranging from academic research institutes to biotechnology and pharmaceutical companies
• Academic and research institutes held a significant share due to wide usage across various studies
• North America dominated the 2020 global market owing to the increasing R&D of robust therapies and disease diagnosis
• Asia-Pacific is projected to witness the fastest CAGR, with India and China at the forefront
• Thermo Fisher Scientific, QIAGEN NV, Illumina Inc., Merck Millipore, BGI, Fluidigm Corporation, and Bio-Rad Laboratories are some prominent entities in this space.
• Companies have focused on the development of new innovative products to gain a competitive advantage

Access Press Release@ https://www.grandviewresearch.com/press-release/global-single-cell-analysis-market

Single-cell Analysis Market Segmentation

Grand View Research has segmented the global single-cell analysis market on the basis of product, application, workflow, end-use, and region:

Single Cell Analysis Product Outlook (Revenue, USD Million, 2017 - 2028)

• Consumables
  • Reagents
  • Assay Kits
• Instruments
  • Microscope
  • Hemocytometers
  • Flow Cytometers
  • NGS Systems
  • PCR
  • High Content Screening Systems
  • Cell Microarrays
  • Single Live Cell Imaging
  • Automated Cell Counters

Single Cell Analysis Application Outlook (Revenue, USD Million, 2017 - 2028)

• Cancer
• Immunology
• Neurology
• Stem cell
• Non-invasive prenatal diagnosis
• In-vitro fertilization
• Others

Single Cell Analysis Workflow Outlook (Revenue, USD Million, 2017 - 2028)

• Single-cell isolation & Library Preparation
• Downstream Analysis
• Data Analysis

Single Cell Analysis End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Academic & Research Laboratories
• Biotechnology and Pharmaceutical Companies
• Hospitals and Diagnostic Laboratories
• Others

Single Cell Analysis Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Key Players of Single-cell Analysis Market

• Thermo Fisher Scientific
• QIAGEN NV
• Illumina Inc.
• Bio-Rad Laboratories
• 10x Genomics Inc.
• Novogene Corporation
• BGI
• Fluidigm Corporation
• Merck Millipore
• Becton, Dickinson & Company

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

CRISPR And Cas Genes Market Expectations Acme Prominent Development in Developed Regions, Details Gvr Study

 CRISPR And Cas Genes Market Growth & Trends

The global CRISPR and cas genes market size is expected to reach USD 7.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 21.7% from 2021 to 2028. The adoption rate and demand for CRISPR gene editing tools have significantly increased in the past few years. CRISPR RNA-guided nuclease Cas9 has improved the genetics arena by facilitating precise and efficient genetic modification of diverse eukaryotic genomes, including human genomes, thereby driving the market.

The outbreak of COVID-19 shifted the focus of researchers towards the development of molecular diagnostic tools for COVID-19 based on this technology. For instance, in March 2021, researchers from Nanyang Technological University, Singapore developed a CRISPR-based COVID-19 test that delivers results in 30 minutes. This test detects the virus even after the mutation. This would encourage other players to leverage this opportunity.

Implementation of this technology in various medical and other non-conventional applications continues to increase. With a rising number of academic institutions and biotech companies working toward the development of new commercial applications of this technology, competition over patents for this gene-editing technology is expected to intensify. Furthermore, the implementation of machine-learning technologies exhibits great potential in advancing this gene-editing technology.

Request a free sample copy or view report summary: CRISPR And Cas Genes Market Report

CRISPR And Cas Genes Market Report Highlights

• The product segment accounted for the largest revenue share in 2020 due to the availability of a wide portfolio and increasing usage across several end-users
• For instance, a large number of screening libraries are available for high-throughput gene editing studies, thereby driving the segment
• Furthermore, the introduction of engineered enzymes along with the combination of different enzymes has attributed to the significant share of this segment
• Technological advancements have resulted in a simplified genome engineering process. This, in turn, contributed to the higher adoption of this technology in cell line engineering
• Biomedical applications are witnessing the highest penetration of this technology. Extensive research for human and non-human genomics has driven the segment
• Biotechnology and pharmaceutical companies are estimated as the largest key end-users of the market
• Reduced cost and time associated with genetic modification along with the availability of investments is anticipated to drive segment growth.
• Also, the global COVID-19 pandemic has driven investment flow in the segment for the development of rapid CRISPR-based POC tests by biotechnology 
• North America dominated the market owing to the presence of a strong research base that is engaged in the development as well as usage of this gene-editing tool.
• Moreover, the U.S. exhibits a well-established market for gene-modified therapies that have positively influenced the adoption of molecular scissors in the region.
• Asia Pacific is anticipated to witness the fastest CAGR throughout the forecast period.
• China has a significant presence in this market and is actively engaged in exploring this space to develop novel therapies.
• Collaborations between global and domestic players for the use of patented CRISPR tools supplemented the regional growth.
• The key companies are focusing on collaboration and new product launches to sustain their position in the global market.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-crispr-associated-cas-genes-market

CRISPR And Cas Genes Market Segmentation

Grand View Research has segmented the global CRISPR and Cas genes market on the basis of product and service, application, end-use, and region:

CRISPR & Cas Genes Product & Service Outlook (Revenue, USD Million, 2017 - 2028)

• By Product
  • Kits & Enzymes
    • Vector-based Cas
    • DNA-free Cas
  • Libraries
  • Design Tool
  • Antibodies
  • Others
• By Service
  • Cell Line Engineering
  • gRNA Design
  • Microbial Gene Editing
  • DNA Synthesis

CRISPR & Cas Genes Application Outlook (Revenue, USD Million, 2017 - 2028)

• Biomedical
  • Genome Engineering
  • Disease Model Studies
  • Functional Genomics
  • Epigenetics
  • Others
• Agricultural

CRISPR & Cas Genes End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Biotechnology & Pharmaceutical Companies
• Academics & Government Research Institutes
• Contract Research Organizations (CROs)

CRISPR & Cas Genes Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • Spain
  • UK.
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of CRISPR And Cas Genes Market

• AstraZeneca plc.
• Addgene
• Caribou Biosciences, Inc.
• Cellectis, CRISPR Therapeutics
• Editas Medicine, Inc.
• eGenesis
• Hoffmann-La Roche Ltd.
• Horizon Discovery Group plc
• GenScript
• Danaher Corporation
• Intellia Therapeutics, Inc.
• Lonza
• Merck KGaA
• Intellia Therapeutics, Inc.
• Takara Bio Inc.
• Thermo Fisher Scientific, Inc.
• Synthego
• Mammoth Biosciences
• Inscripta, Inc.
• Cibus
• Beam Therapeutics
• PLANTeDIT
• Vertex Pharmaceuticals Incorporated
• Hera BioLabs
• OriGene Technologies, Inc.
• Recombinetics, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Flexible Packaging Market Will Target Emerging Markets By 2028

 Medical Flexible Packaging Market Growth & Trends

The global medical flexible packaging market size is expected to reach USD 26.3 billion by 2028, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.5% from 2021 to 2028. Increasing demand for pharmaceutical products in emerging economies as well as growing demand for drug delivery systems in developed countries are driving the growth of the market. The use of flexible packaging is increasing in the healthcare industry as the companies operating in the industry are opting for sustainable functions and materials, such as paper. Paper-based packaging is included in green packaging as it is highly recyclable and economical.                                                     

The flexible packaging is well suitable for single-time use. This is especially beneficial in the packaging of single-use products, which are becoming increasingly popular to avoid the risk of cross-contamination. The products can be sterilized along with the packaging, which has reduced the chance of contamination while manufacturing the products.

The most widely used materials in the market are plastics followed by metal, paper, and bioplastics. Bioplastics are becoming increasingly popular due to government regulations regarding plastic usage & waste, as well as initiatives by several companies to adopt sustainable operations. The high tensile strength and the wide variety of products available in plastics, along with its low cost, have made it a preferable choice over its metal counterparts for packaging in the healthcare industry.

High-barrier films are largely utilized across the healthcare industry as they prevent the permeation of light, gas, flavor, aroma, oxygen, oil, water vapor, and water. These films are available in a wide variety, making them compatible with most equipment and drugs; additionally, most high-barrier film providers offer packaging made from a variety of materials to establish a one-stop solution for drug & equipment manufacturers. The high-barrier films segment is thus expected to show the highest growth rate over the forecast period.

Biologics and other such patient-oriented medicines are expected to have a positive impact on the pharmaceutical manufacturing end-use segment. The demographic trends, such as increasing cases of obesity as well as growing aging population, are expected to drive the segment further. In addition, the advancements in bioengineering and rising awareness about cosmetic implants are aiding the implant manufacturing segment.

Request a free sample copy or view report summary: Medical Flexible Packaging Market Report

Medical Flexible Packaging Market Report Highlights

• The plastics material segment dominated the market with a revenue share of 74.39% in 2020 and will grow steadily over the forecast years due to the easy availability of superior-quality medical-grade plastics
• In addition, growing research & development activities focused on inducing inert properties in plastics are expected to increase the demand for plastics in new applications
• Pouches and bags accounted for the largest revenue share in 2020. Pouches & bags are sturdy and lightweight, which makes them an ideal packaging solution for numerous products, including ones that are usually packed in rigid packaging
• Central & South America is expected to witness a CAGR of 5.9% over the forecast period on account of growing investments by private companies in the healthcare sector and rising cases of chronic diseases across the region
• Major companies focus on mergers and acquisitions to expand their reach and compete with rival companies. The merger valuations of companies in the market are expected to increase as an attempt to achieve product leadership in individual categories
• Restructuring and divestment strategies are adopted as well to focus on particular products to establish a monopoly for the same. Companies are expected to find a balance between innovations and investments to establish an eco-friendly and cost-effective process along with regulating price levels

Access Press Release@ https://www.grandviewresearch.com/press-release/global-medical-flexible-packaging-market

Medical Flexible Packaging Market Segmentation

Grand View Research has segmented the global medical flexible packaging market on the basis of material, product, end-use, and region:

Medical Flexible Packaging Material Outlook (Revenue, USD Million, 2017 - 2028)

• Plastics
  • Polyvinyl Chloride
  • Polypropylene
  • Polyethylene Terephthalate
  • Polyethylene
  • Others
• Paper
• Aluminum
• Bioplastics

Medical Flexible Packaging Product Outlook (Revenue, USD Million, 2017 - 2028)

• Seals
• High Barrier Films
  • Biaxially Oriented Polyethylene Terephthalate (BOPET)
  • Ethylene Vinyl Alcohol (EVA)
  • Polyacrylonitrile
  • Silicon Oxide
  • Aluminum Oxide
  • Polyvinylidene Chloride
  • Others
• Wraps
• Pouches & Bags
• Lids & Labels
• Others

Medical Flexible Packaging End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Pharmaceutical Manufacturing
• Medical Device Manufacturing
• Implant Manufacturing
• Contract Packaging
• Others

Medical Flexible Packaging Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK.
• Asia Pacific
  • China
  • Japan
  • India
• Central & South America (CSA)
  • Brazil
• Middle East & Africa (MEA)
  • South Africa

List of Key Players of Medical Flexible Packaging Market

• Bemis Company, Inc.
• WestRock, Aptar, Inc.
• Dätwyler Holding, Inc.
• Becton, Dickinson & Company
• Berry Global
• Catalent Pharma Solutions
• Coveris S.A.
• Winpak Ltd.
• Sealed Air
• Amcor
• Mondi
• Huhtamäki Oyj
• CCL Industries, Inc.
• Gerresheimer

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Single-use Bioprocessing Market Top Players ,Analysis And Forecast Till 2028: Grand View Research Inc.

 Single-use Bioprocessing Market Growth & Trends

The global single-use bioprocessing market size is expected to reach USD 51.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 16.0% from 2021 to 2028. The adoption rate and demand for single-use equipment have significantly increased in the past few years. This is due to the commercial advantages including cost and time-saving advantages associated with it, thereby driving the market.

The growing adoption of the equipment by in-house as well as contract biomanufacturers has spurred the investment flow in this space. Also, the market is witnessing notable advancements in various product portfolios such as stirring systems, bioreactor designs, disposable probes and sensors, and film technologies, thereby leading to strong revenue growth. Furthermore, the implementation of big data and machine-learning technologies exhibits great potential in advancing single-use-based biomanufacturing processes.

Several manufactures have begun shifting towards automation to ease the process and reduce cost margin. Besides, considering the improved efficiency of disposables in accelerating the biopharmaceuticals production, end-users are undertaking various initiatives to convert their bioprocessing unit into a single-use unit. This is anticipated to create lucrative opportunities for the operating technology and product supplier in the market during the forecast period.

Request a free sample copy or view report summary: Single-use Bioprocessing Market Report

Single-use Bioprocessing Market Report Highlights

• The simple and peripheral elements segment accounted for the largest revenue share in 2020 due to diversification of products as well as their frequent usage
• For instance, disposable probes and sensors are witnessing robust growth in terms of adoption within the biopharmaceutical industry, thereby driving the segment
• Furthermore, the introduction of single-use bags integrated with adapters, automation, tubing, ports, connectors, and sensors have attributed to the significant share of this segment
• The apparatus and plants segment is anticipated to grow at a significant pace owing to the expanding applications of products offered in this segment
• The flexibility offered by single-use bioreactor technology is one of the key factors driving investment in the segment
• Furthermore, the presence of a wide array of products for both upstream and downstream processing has resulted in the large revenue share of this segment
• Biopharmaceutical manufacturers are estimated as the largest key end-users of the market
• Facility expansion and increasing adoption of disposables by contract manufacturing organizations is playing a vital role in accelerating the biopharmaceutical manufacturing industry
• North America dominated the market owing to the presence of strong research as well as the commercial base for biopharmaceutical manufacturing
• Moreover, the U.S. is the largest biopharmaceutical market that has positively influenced the adoption of single-use technologies in the region
• The shifting focus of U.S.-based companies from conventional manufacturing practices to disposable manufacturing systems also drives regional growth
• Asia Pacific is estimated to witness the fastest growth with emerging markets such as China and Japan at the forefront
• Collaborations between domestic and global players for expansion of biomanufacturing capabilities is driving the market in the Asia Pacific
• Key companies are focusing on new product launches to sustain their position in the market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-single-use-bioprocessing-market

Single-use Bioprocessing Market Segmentation

Grand View Research has segmented the global single-use bioprocessing market on the basis of product, workflow, end-use, and region:

Single-use Bioprocessing Product Outlook (Revenue, USD Million, 2017 - 2028)

• Simple & Peripheral Elements
  • Bags
  • Tubing, Filters, Connectors, & Transfer Systems
  • Sampling Systems
  • Probes & Sensors
    • pH Sensor
    • Oxygen Sensors
    • Pressure Sensors
    • Temperature Sensors
    • Conductivity Sensors
    • Flow Sensors
    • Other sensors
  • Others
• Apparatus & Plants
  • Bioreactors, By Capacity
    • Up to 1000L
    • Above 1000L to 2000L
    • Above 2000L
  • Filtration system
  • Mixing, Storage, & Filling Systems
  • Chromatography Systems
  • Pumps
  • Others
• Work Equipment
  • Cell Culture System
  • Syringes
  • Others

Single-use Bioprocessing Workflow Outlook (Revenue, USD Million, 2017 - 2028)

• Upstream
• Fermentation
• Downstream

Single-use Bioprocessing End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Biopharmaceutical Manufacturer
  • CMOs & CROs
  • In-house Manufacturer
• Academic & Clinical Research Institutes

Single-use Bioprocessing Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • Spain
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players in Single-use Bioprocessing Market

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Sartorius AG
• Corning Incorporated
• Pall Corporation
• General Electric Company (GE Healthcare)
• Eppendorf AG
• Rentschler Biopharma SE
• Lonza
• Meissner Filtration Products, Inc.
• JM BioConnect
• Boehringer Ingelheim GmbH
• Infors AG
• PBS Biotech, Inc.
• Entegris, Inc.
• Danaher Corporation
• Kuhner AG
• Rentschler Biopharma SE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Augmented Reality & Virtual Reality in Healthcare Market Expanding At A CAGR Of 27.2% From 2021 To 2028: Grand View Research Inc.

 

Augmented Reality & Virtual Reality In Healthcare Market Growth & Trends

The global augmented reality & virtual reality in healthcare market size is expected to reach USD 9.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 27.2% from 2021 to 2028. Increasing advancements and digital disruptions in the healthcare system, rising healthcare expenditure, and the rising need for efficient and innovative solutions to enhance clinical and operational outcomes are contributing to the growth of the market. Augmented reality (AR) and virtual reality (VR)technologies are witnessing widespread adoption in surgical departments, simulation labs, education and training, and chronic pain management.

The rising number of complex surgeries is driving the demand for VR-based models to assist the surgeon. AR-based apps are used in multiple spaces such as training and education modules and patient care management tools. Innovators are receiving recognition in the form of increased investments by venture capitalists and collaboration opportunities by established players. For instance, in September 2020 OssoVR rose funding of USD 14.0 million and planned to utilize the funding towards developing virtual reality-based surgical and medical device training modules.

The hardware component segment witnessed the highest adoption owing to the rising adoption of AR and VR into different fields of healthcare. These devices range from desktops to wearable devices to display devices. Due to their audio-visual significance AR and VR is being widely adopted in education, simulation, telemedicine, and data visualization. Increasing product development in this space is contributing to market growth. For instance, in February 2019 Philips Healthcare launched a mixed reality solution by collaborating with Azurion and Microsoft. However, the services segment is expected to witness a significant CAGR during the forecast period owing to the growing need to create an immersive experience for the customer. The rising adoption in clinical trials, psychological treatment, advanced diagnostics, surgeries, and body mapping is expected to support market growth.

In addition, AR technological solutions are widely used in surgical procedures, fitness management, education and training, patient care management, medical imaging and is expected to be implemented in many more functionalities. Recent advancements in AR components have reduced the cost of augmented reality solutions and enhanced customer experience. The increasing prevalence of diseases and surgeries along with advancements in healthcare infrastructure and IT are some of the driving forces. Medical education and training using augmented reality technological solutions is also emerging rapidly and is expected to support growth. On the other hand, virtual reality technology is expected to be the fastest-growing region during the forecast period owing to the rapid integration of technology into healthcare services. VR technological solutions are widely used in telemedicine, anatomy visualization, and diagnostics. Additionally, it provides hands-on experience in medical education which is expected to contribute to market growth.

Request a free sample copy or view report summary: Augmented Reality & Virtual Reality In Healthcare Market Report

Augmented Reality & Virtual Reality In Healthcare Market Report Highlights

• The market is anticipated to grow well over the forecast period owing to the rapidly transforming and digitalization of the healthcare space
• Hardware component segment dominated the global augmented reality and virtual reality in healthcare market in 2020, owing to increased use in training, simulation, surgeries, and diagnostics
• The augmented reality technology segment dominated the market in 2020 owing to the growing adoption of inpatient care management, training and education, and medical imaging
• North America dominated the market in 2020 owing to sophisticated healthcare infrastructure and widespread awareness of the benefits of AR and VR in healthcare

Access Press Release@ https://www.grandviewresearch.com/press-release/global-augmented-reality-ar-virtual-reality-vr-in-healthcare-market

Augmented Reality & Virtual Reality In Healthcare Market Segmentation

Grand View Research has segmented the global augmented reality & virtual reality in healthcare market on the basis of component, technology, and region:

AR & VR In Healthcare Component Outlook (Revenue, USD Million, 2016 - 2028)

• Hardware
• Software
• Service

AR & VR In Healthcare Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Augmented Reality
  • Surgical Application
  • Rehabilitation
  • Training and Medical Education
• Virtual Reality
  • Virtual Reality Exposure Therapy (VRET)
  • Simulation
  • Rehabilitation
  • Diagnostics
  • Pain Distraction

AR & VR In Healthcare Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Spain
  • France
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in the Augmented Reality And Virtual Reality In Healthcare Market

• CAE
• GE Healthcare
• Koninklijke Philips N.V.
• Intuitive Surgical
• Siemens Ltd
• Eon Reality, Inc
• Layar
• Bioflight VR
• WorldViz
• TheraSim Inc
• Mindmaze

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Thermal Spray Coatings Market Size Projected to Rise Lucratively by 2028: Grand View Research Inc

 

Thermal Spray Coatings Market Growth & Trends

The global thermal spray coatings market size is projected to reach USD 14.1 billion by 2028, registering a CAGR of 4.1% over the forecast period, according to a new report by Grand View Research, Inc. The global market is anticipated to be driven by the increasing product application scope owing to advantages, such as wear and corrosion protection, low toxic gas emissions, thickness capability, and electrical resistance.

Thermal spraying is used to improve or restore the surface of a solid material. It can also be used for applying coatings to a wide range of components and materials for better resistance against cavitation, wear, abrasion erosion, and heat. Approximately, 40 to 45% of paints & coatings produced globally are used as protective and decorative paints in the architecture industry. These can be used either for existing or newly constructed structures including monuments, private offices, residential buildings, plants & factories, and public buildings.

China, India, and Indonesia are majorly contributing to the growth of the construction industry in Asia Pacific. The rising population coupled with rapid urbanization & industrialization, especially in the aforementioned economies, has encouraged governments to increase their construction spending and boost infrastructural development. Furthermore, the rising popularity of powder-based coatings owing to the low cost is also significantly contributing to the growth of the global coatings market. Various rules are applicable, in terms of the manufacturing of coatings, due to the carcinogenic and flammable nature of solvents.

However, powder-based coatings are eco-friendly as they contain no solvents and hence do not lead to Volatile Organic Compounds (VOCs), which cause air pollution. The Covid-19 pandemic has severely disrupted supply chains and sharply curtailed product demand. Restriction in transportation and supply due to slowdown or halting of factories and partial or nationwide lockdowns in several countries to restrain the spread of the coronavirus are expected to have an adverse impact on market growth 

Request a free sample copy or view report summary: Thermal Spray Coatings Market Report

Thermal Spray Coatings Market Report Highlights

• The aerospace application segment dominated the market with a revenue share of 32.2% in 2020
• The high growth is attributed to the wide product usage in aerospace applications as it helps reduce the high-temperature effects on components and increase their lifespan
• Ceramicswas the dominant product segment and accounted for the highest revenue share in 2020
• This growth is credited to the high demand for these products from the industries, such as healthcare, aerospace & defense, energy, and industrial goods
• The global market is highly competitive because of the presence of several medium- and small-scale companies across the globe
• Key manufacturers focus on developing innovative formulas to offer diverse and high-quality products

Access Press Release@ https://www.grandviewresearch.com/press-release/global-thermal-spray-coating-market

Thermal Spray Coatings Market Segmentation

Grand View Research has segmented the global thermal spray coatings market on the basis of product, technology, application, and region:

Thermal Spray Coating Product Outlook (Revenue, USD Million, 2016 - 2028)

• Metals
• Ceramics
• Intermetallics
• Polymers
• Carbides
• Abradables
• Others

Thermal Spray Coating Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Cold
• Flame
• Plasma
• High-Velocity Oxy-Fuel (HVOF)
• Electric Arc
• Others

Thermal Spray Coating Application Outlook (Revenue, USD Million, 2016 - 2028)

• Aerospace
• Industrial Gas Turbine
• Automotive
• Medical
• Printing
• Oil & Gas
• Steel
• Pulp & Paper
• Others

Thermal Spray Coating Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Finland
  • Denmark
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • Malaysia
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • United Arab Emirates (UAE)
  • Oman

List of Key Players of Thermal Spray Coatings Market

• Praxair Surface Technologies, Inc.
• C. Starck, Inc.
• Wall Colmonoy Corp.
• Powder Alloy Corp.
• Saint-Gobain S.A.
• Carpenter Technology Corp.
• Durum Verschleiss-Schutz GmbH
• Montreal Carbide Co. Ltd.
• Progressive Surface, Inc.
• American Roller Company, LLC
• Lincotek Surface Solutions
• John Wood Group PLC
• Air Products and Chemicals, Inc.
• Metallizing Equipment Co. Pvt. Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.